Senexin C is a novel orally active and specific CDK8/19 inhibitor with potential anticancer activity.Senexin C is more metabolically stable and potent than Senexin B. Senexin C inhibits the growth of MV4-11 leukaemia cells.
Molecular Weight:
449.55
Purity:
98.06%
CAS Number:
[2375554-02-0]
Formula:
C28H27N5O
Target:
CDK
T62702
* VAT and and shipping costs not included. Errors and price changes excepted